Justin Waryold, NP
Adult Health · Nesconset, NYNPI 1619148327
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Gilead accounts for 82.3% of it on its own, with 29 other manufacturers making up the rest. 2025 is the largest year on record at $12,442, more than ten times the $424 reported in 2021. Among adult health clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 170 payments — averaging $89.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$13K
- Viiv Healthcare Company$838
- AstraZeneca$383
- Novo Nordisk$238
- Merck$177
- Pfizer$144
- plus $922 from 24 others
What the payments were for
- Speaking & faculty fees$8,42555%
- Travel & lodging$2,99320%
- Food & beverage$3,75025%
- Education$660%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 49 | $12,532 |
| Viiv Healthcare Company | 31 | $838 |
| AstraZeneca | 19 | $383 |
| Novo Nordisk | 13 | $238 |
| Merck | 8 | $177 |
| Pfizer | 8 | $144 |
| Astellas Pharma US Inc | 4 | $131 |
| AbbVie | 7 | $130 |
| Exact Sciences | 3 | $70 |
| Abbott | 3 | $62 |
| Lundbeck LLC | 2 | $43 |
| Boehringer Ingelheim | 2 | $42 |
| Dynavax Technologies Corporation | 2 | $39 |
| Lilly USA, LLC | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $36 |
| Currax Pharmaceuticals LLC | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Johnson & Johnson | 1 | $26 |
| Insulet Corporation | 1 | $25 |
| Microtransponder, Inc. | 1 | $25 |
| Almatica Pharma LLC | 1 | $25 |
| Clarus Therapeutics Inc. | 1 | $23 |
| Sanofi Pasteur Inc. | 1 | $23 |
| Shield Therapeutics Inc | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Amgen | 1 | $19 |
| GSK | 1 | $16 |
| Antares Pharma, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,234 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 17 | $69,079 |
| DescovyEmtricitabine/Tenofov Alafenam | 16 | $55,185 |
| EliquisApixaban | 15 | $23,209 |
| JanuviaSitagliptin Phosphate | 11 | $15,195 |
| DapagliflozinDapagliflozin Propanediol | 12 | $6,880 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 12 | $6,517 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $4,447 |
| OxycontinOxycodone Hcl | 13 | $4,089 |
| Icosapent Ethyl | 11 | $3,344 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 39 | $1,640 |
| Atorvastatin Calcium | 113 | $1,188 |
| Potassium Chloride | 20 | $1,074 |
| Rosuvastatin Calcium | 73 | $1,050 |
| Metoprolol Succinate | 47 | $884 |
| Gabapentin | 44 | $807 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy | $12,532 | $124,26433 claims |
| PfizerEliquis | $144 | $23,20915 claims |
| MerckJanuvia, Janumet Xr | $177 | $21,71223 claims |
| GSKBreo Ellipta | $16 | $4,44714 claims |
| Almatica Pharma LLCSertraline Hcl | $25 | $20315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,828 adult health providers in New York.
Other adult health in Nesconset
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Mary CiechoskiBuffalo$200K
- Jennifer FioriniGlens Falls$151K
- Katelyn McCormackAmherst$131K
- Maria Gigante-BaggettEast Syracuse$92K
- Jane PattersonRochester$66K
- Alyson HartyNew York$65K
- Danielle BrunoPlainview$61K
- Julie PlantamuraPort Jefferson Station$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.